Home›Companies›Biotech & Pharma›Amprion

Amprion, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 27, 2024·Suggest an edit

About Amprion

Amprion is a private company based in San Francisco, California. It has reported $16,718,331 raised in two offerings on Form D since July 2022. Its chief executive is Russell Lebovitz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 10, 2024Sep 25, 2024amended Sep 27, 2024$5,761,371of $15.0M target7$823KEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 24, 2022Jul 15, 2022$10,956,960fully sold9$1.2MEquityRule 506(b)Form D ↗
Total, two offerings$16,718,331

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amprion's Form D filed Sep 27, 2024.

MC
Marc Chan
Director & Stockholder
RL
Russell Lebovitz
Director, CEO & Stockholder
RB

Earlier filings also listed Peter Clinton (director, last listed Jul 2022), Kenneth Lehman (director & stockholder, last listed Jul 2022) and Claudio Soto (director & stockholder, last listed Jul 2022).

Sources

  1. SECAmprion, Inc. Form D, filed Sep 25, 2024
  2. SECAmprion, Inc. filing history